LCH

Investigation Using DNS Microarrays of the Expression of Matrix Metalloproteinases in Normal and Langerhans Cells

Investigating Chemokine Receptor Usage as an Explanation for the Aberrant Behaviour of CD1a Cells in LCH

FLT3 Ligand in LCH

Biologic Correlates of Response to Therapy in LCH

LCH-III Clinical Trial

Evaluation of Thalidomide for Treatment of Resistant Langerhans Cell Histiocytosis

Analysis of the Tumor Necrosis Factor Receptor Pathway in LCH

Epidemiology Study of LCH in Children in a Special Population Group

Targeted Imaging & Therapy with Humanized Anti-CD1a ScFv Antibody Conjugates for Langerhans Cell Histiocytosis

Mouse Model of Langerhans Cell Histiocytosis